Memoplant

Memoplant – the vegetable drug promoting improvement of cerebral and peripheric circulation.

Form of release and structure

Memoplant release in the form of tablets, film coated: on 40 mg – round, smooth, brownish-yellow; on 80 and 120 mg – biconvex, round, brownish-red, on a break – from brownish-yellow till light yellow color (on 10, 15 or 20 pieces in blisters, on 1-3,5 blisters in a cardboard pack).

Is a part of 1 tablet:

• Active agent: leaves of a ginkgo bilobed (in the form of dry extract (EGb 761) 35-67:1) – 40, 80 or 120 mg (standardized according to contents (respectively): flavonglikozid – 9,6/19,2/28,8 mg, terpenlakton – 2,4/4,8/7,2 mg);
• Auxiliary components (tablets on 40/80/120 mg respectively): monohydrate of lactose – 115/45,5/68,25 mg, colloid silicon dioxide – 2,5/2/3 mg, microcrystallic cellulose – 60/109/163,5 mg, corn starch – 25/10/15 mg, croscarmellose sodium – 5/10/15 mg, magnesium stearate – 2,5/3,5/5,25 mg;
• Cover (tablets on 40/80/120 mg respectively): a gipromelloza – 9,25/9,25/11,5728 mg, a macrogoal of 1500 – 4,625/4,625/5,7812 mg, a penogasyashchy emulsion of SE2 – 0,008/0,008/0,015 mg, titanium dioxide (E171) – 0,892/0,892/1,626 mg, ferrous hydroxide (E172) – 1,16/0/0 mg, iron oxide brown (E172) – 0/0,146/0 mg, iron oxide red (E172) – 0/0,503/1,3 mg, talc – 0,576/0,576/0,72 mg.

Extragent: acetone of 60%.

Indications to use

• Functional disturbances of a brain (including age) which are connected with disturbance of cerebral circulation and are followed by such symptoms as dizziness, a memory impairment, a sonitus, a headache, decrease in mental abilities and ability to concentration of attention;
• The functional disturbances of an inner ear which are shown a sonitus, unstable gait and dizziness;
• Disturbances of peripheric circulation, including the obliterating diseases of arteries of the lower extremities which are shown the alternating lameness, numbness and a cold snap of feet, a Raynaud's disease.

Contraindications

• Disturbances of cerebral circulation (at an acute current);
• Acute myocardial infarction;
• Erosive gastritis;
• Decrease in coagulability of blood;
• Peptic ulcer of a stomach and duodenum (at an aggravation);
• Age up to 12 years (for tablets on 40 mg) or up to 18 years (for tablets on 80 and 120 mg);
• Hypersensitivity to drug components.

It is not recommended to the feeding and pregnant women to accept Memoplant that is connected with lack of sufficient clinical data.

Because of the lactose which is Memoplant's part, it is not recommended to appoint him the patient with an inborn galactosemia, a sprue of a galactose or glucose or at an inborn lactose intolerance.

Route of administration and dosage

Memoplant accept inside, regardless of meal. The tablet is not chewed and wash down with a small amount of water.

At the accidental admission of administration of drug, the following single dose should not be increased.

The mode of dosing is defined by indications:

• Frustration of cerebral circulation (symptomatic treatment): on 1-2 tablets (40 mg) 3 times a day, or on 1 tablet (80 mg) 2-3 times a day, or on 1 tablet (120 mg) 1-2 times a day. Therapy duration – is not less than 8 weeks;
• Disturbances of peripheric circulation: on 1 tablet (40 mg) 3 times a day, or on 1 tablet (80 mg) 2 times a day, or on 1 tablet (120 mg) 1-2 times a day. Therapy duration – is not less than 6 weeks;
• Vascular or involutional pathology of an inner ear: on 1 tablet (40 mg) 3 times a day, or on 1 tablet (80 mg) 2 times a day, or on 1 tablet (120 mg) 1-2 times a day. Therapy duration – 6-8 weeks.

In the absence of improvement for 3 months of therapy it is necessary to discuss expediency of further reception of Memoplant with the doctor.

Side effects

• Coagulant system of blood: decrease in coagulability of blood; in some cases – bleedings at the patients who were at the same time accepting the means leading coagulability of blood to decrease;
• Central nervous system: seldom – dizziness, a headache, a hearing disorder;
• Allergic reactions: skin rash, reddening, itch, puffiness of skin;
• Others: seldom – gastrointestinal frustration in the form of vomiting, nausea and diarrhea.

At development during Memoplant's use of side effects it is necessary to interrupt therapy and to see behind consultation a doctor.

Special instructions

At often arising dizzinesses, a sonitus, and also in case of sudden loss or deterioration in hearing it is necessary to consult with the doctor.

Medicinal interaction

Combined use of Memoplant with acetylsalicylic acid, anticoagulants (indirect and direct action) and drugs reducing coagulability of blood is not recommended.

Terms and storage conditions

To store in the place, unavailable to children, at a temperature of 15-25 °C.

Period of validity:

• Tablets on 40 and 80 mg – 5 years;
• Tablets on 120 mg – 3 years.